Equipment and Infrastructure
Facilities Naming Opportunities
The brand new 139,000-square-foot Biomedical Research Addition provides state-of-the-art research laboratories that focus in six thematic areas of research:
- Biomaterials and body-device interfaces
- Cardiovascular science
- Comparative oncology
- Infectious disease and immunity (COVID-19 Research)
- Metabolism and Obesity
These facilities will be home to 25+ new research teams by 2027. The new space already houses an active cardiovascular research lab, a brain cancer research lab, a high-field magnet for brain and heart imaging, and the veterinary college’s new Animal Cancer Care and Research Center. The expansion also includes Virginia Tech’s COVID-19 testing laboratory, and a new biological safety level three facility where our researchers will work on identifying the mechanisms of COVID-19-induced disease and therapeutics.
In addition, the Fralin Biomedical Research Institute and Virginia Tech are expanding research operations to the Children's National Research & Innovation Campus in Washington, D.C. The new laboratories in D.C., anticipated to open in 2021, will be home to a team of Virginia Tech scientists who will work alongside researchers and clinicians at Children's National and JLabs to develop new diagnostics and therapeutics to treat pediatric nervous system cancers.
To attract and retain the world's top scientists, the Fralin Biomedical Research Institute is always seeking opportunities to invest in cutting-edge equipment. Our researchers help companies test and develop new equipment and techniques. These partnerships benefit their research because they provide access to brand new equipment.
Bio ItemMartha Quinn , bio
Assistant Vice President for Advancement, Health Sciences and Technology and the Fralin Biomedical Research Institute at VTC
Bio ItemKatie McCrystal , bio
Associate Director of Advancement, Health Sciences and Technology and the Fralin Biomedical Research Institute at VTC